| Schedule of Impact on Restated Condensed Consolidated Financial Statements |
The impact of the restatement on the condensed consolidated financial statements for March 31, 2026 is presented below. The accompanying notes to the unaudited consolidated interim financial statements have been restated as applicable. The restatement had no impact on net cash flows from operating, investing or financing activities. Condensed Consolidated Balance Sheets | | | | | | | | | | | | | | | | | | | March 31, 2026 | | As Previously Reported | | Adjustments | | As Restated | | Convertible debt | $ | 23,283 | | | $ | 15,836 | | | $ | 39,119 | | | Total liabilities | 110,276 | | | 15,836 | | | 126,112 | | | Accumulated other comprehensive income | 3,189 | | | (1,001) | | | 2,188 | | | Accumulated deficit | (75,032) | | | (14,835) | | | (89,867) | | | Total stockholders' equity | 35,102 | | | (15,836) | | | 19,266 | |
Condensed Consolidated Statements of Operations and Comprehensive Loss | | | | | | | | | | | | | | | | | | | Three Months Ended March 31, 2026 | | As Previously Reported | | Adjustments | | As Restated | | Change in fair value of convertible debt | $ | 5,203 | | | $ | (14,835) | | | $ | (9,632) | | | Total other (expense) income | 2,850 | | | (14,835) | | | (11,985) | | | Net loss before provision for income taxes | (10,238) | | | (14,835) | | | (25,073) | | | Net loss | (10,238) | | | (14,835) | | | (25,073) | | | Net loss per common share - basic and diluted | $ | (3.09) | | | (4.48) | | | $ | (7.57) | | | | | | | | | Other comprehensive income: | | | | | | | Change in fair value of convertible debt due to instrument credit risk | $ | 3,189 | | | (1,001) | | | $ | 2,188 | | | Comprehensive loss | (7,049) | | | (15,836) | | | (22,885) | |
Condensed Consolidated Statements of Changes in Stockholders’ Equity (Deficit) | | | | | | | | | | | | | | | | | | | Three Months Ended March 31, 2026 | | As Previously Reported | | Adjustments | | As Restated | | Change in fair value of convertible debt due to instrument credit risk | $ | 3,189 | | | $ | (1,001) | | | $ | 2,188 | | | Net loss | (10,238) | | | (14,835) | | | (25,073) | | | Accumulated other comprehensive income at March 31, 2026 | 3,189 | | | (1,001) | | | 2,188 | | | Accumulated deficit at March 31, 2026 | (75,032) | | | (14,835) | | | (89,867) | | | Total stockholders' equity at March 31, 2026 | 35,102 | | | (15,836) | | | 19,266 | |
Condensed Consolidated Statements of Cash Flows | | | | | | | | | | | | | | | | | | | Three Months Ended March 31, 2026 | | As Previously Reported | | Adjustments | | As Restated | | Net loss | $ | (10,238) | | | $ | (14,835) | | | $ | (25,073) | | | Change in fair value of convertible notes | (5,203) | | | 14,835 | | | 9,632 | |
|